Legislation by State Representative Tim O’Brien to establish new grant programs for pediatric and breast cancer research has successfully passed through the Indiana legislature. The bill, known as House Enrolled Act 1453, is now awaiting approval from the governor.
The legislation aims to create specific programs, namely the Pediatric Cancer Research and Treatment Grant Program and the Breast Cancer Research Fund. These grants are intended to promote innovative research for new cancer treatments.
Rep. O’Brien commented on the importance of the bill, stating, “This legislation will help expand critical cancer research and treatment in Indiana. By establishing a dedicated grant program, this new law would support innovation and improve outcomes for Hoosiers battling cancer, giving more families hope. I’m grateful for the strong bipartisan support in both chambers and look forward to seeing this legislation signed into law.”
Statistics from the Indiana Department of Health indicate that over 300 new cases of pediatric cancer occur annually among Hoosier children aged 0 to 19. Moreover, more than 30 children in the state die from cancer each year.
The national perspective from the American Cancer Society estimates that over 9,000 children in the U.S. will be diagnosed with cancer in the coming year. Cancer remains the second leading cause of death among children aged 1 to 14, with more than 1,000 fatalities expected for those under 15 years old.
O’Brien highlighted the potential benefits of the legislation, noting that the grant programs could lead to the development of new therapies in Indiana that might be applied across the United States.
House Enrolled Act 1453 received unanimous support in the Indiana General Assembly, marking a significant step forward in the fight against cancer.
Further information about the bill can be found on the Indiana General Assembly’s website at iga.in.gov.
